Search - tctmd.com

Displaying 1 - 20 of 28

Sort: Relevancy | Date

Year in Review: New Guidelines, Inclisiran, Dapagliflozin Impact CVD Prevention in 2019

News Daily News

Year in Review: New Guidelines, Inclisiran, Dapagliflozin Impact CVD Prevention in 2019

Yael L. Maxwell

December 20, 2019

Hybrid Approach to Reshaping Left Ventricle Offers Hope for HF Patients

News Daily News

Hybrid Approach to Reshaping Left Ventricle Offers Hope for HF Patients

December 06, 2019

VICTORIA Trial of Vericiguat for Worsening HF Meets Primary Endpoint

News Daily News

VICTORIA Trial of Vericiguat for Worsening HF Meets Primary Endpoint

November 20, 2019

As the US Ages, Uptick Seen in Number of Deaths Due to Heart Disease

News Daily News

As the US Ages, Uptick Seen in Number of Deaths Due to Heart Disease

November 04, 2019

Women More Likely Than Men to Develop Heart Failure After STEMI

News Daily News

Women More Likely Than Men to Develop Heart Failure After STEMI

November 04, 2019

Deaths After Ablation of Atrial Fibrillation ‘Concerning’ in Real-World Analysis

News Daily News

Deaths After Ablation of Atrial Fibrillation ‘Concerning’ in Real-World Analysis

Michael O'Riordan

October 29, 2019

Multiarterial CABG ‘Underused’ in Contemporary Practice, Decreases Mortality

News Daily News

Multiarterial CABG ‘Underused’ in Contemporary Practice, Decreases Mortality

Yael L. Maxwell

October 28, 2019

Repeat Target-Lesion PCI: An Option for Public Reporting?

News Daily News

Repeat Target-Lesion PCI: An Option for Public Reporting?

Michael O'Riordan

October 25, 2019

Dapagliflozin Gets Expanded Indication for Prevention of HF Hospitalization in Type 2 Diabetes

News Daily News

Dapagliflozin Gets Expanded Indication for Prevention of HF Hospitalization in Type 2 Diabetes

October 21, 2019

Risk Prediction Model Personalizes Revascularization Options for FREEDOM-Like Patients

News Daily News

Risk Prediction Model Personalizes Revascularization Options for FREEDOM-Like Patients

Michael O'Riordan

October 17, 2019

High-Sensitivity Troponin T May Offer Glimpse Into Future HF Risk: ARIC Analysis

News Daily News

High-Sensitivity Troponin T May Offer Glimpse Into Future HF Risk: ARIC Analysis

September 13, 2019

Artificial Intelligence Mines ECG Data to Estimate ‘Physiologic Age’

News Daily News

Artificial Intelligence Mines ECG Data to Estimate ‘Physiologic Age’

Yael L. Maxwell

August 27, 2019

Oral Anticoagulation Post-AVR Safe but Not Routinely Needed: PARTNER II

News Daily News

Oral Anticoagulation Post-AVR Safe but Not Routinely Needed: PARTNER II

August 27, 2019

STICH Myocardial Viability at 10 Years: Still No Link With CABG Effects

News Daily News

STICH Myocardial Viability at 10 Years: Still No Link With CABG Effects

August 21, 2019

DAPA-HF: Dapagliflozin Scores a Win in Heart Failure

News Daily News

DAPA-HF: Dapagliflozin Scores a Win in Heart Failure

August 20, 2019

FDA Approves Baroreflex Activation Therapy Device for Advanced Heart Failure

News Daily News

FDA Approves Baroreflex Activation Therapy Device for Advanced Heart Failure

August 19, 2019

Proportionate and Disproportionate MR: A ‘Framework’ for MitraClip and Medical Therapy

News Daily News

Proportionate and Disproportionate MR: A ‘Framework’ for MitraClip and Medical Therapy

May 09, 2019

Digging In: Adherence to Plant-Based Diets Linked to Fewer HF Hospitalizations

News Daily News

Digging In: Adherence to Plant-Based Diets Linked to Fewer HF Hospitalizations

April 23, 2019

Most STEMI Patients Head to ICU After PCI, but Not All Need to Go

News Daily News

Most STEMI Patients Head to ICU After PCI, but Not All Need to Go

Michael O'Riordan

April 15, 2019

Stem Cell Research—Shattered After Fabrication Scandal—Needs to Rebuild, Says EHJ Editor

News Daily News

Stem Cell Research—Shattered After Fabrication Scandal—Needs to Rebuild, Says EHJ Editor

Michael O'Riordan

April 12, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.